Login / Signup

Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?

Liza-Marie Marie JohnsonDevan M DuenasBenjamin S Wilfond
Published in: The American journal of bioethics : AJOB (2020)
Keyphrases
  • electronic health record
  • big data
  • case control
  • early life
  • decision making
  • childhood cancer
  • data analysis